First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.

(Both categories represent major patient complaints: nightly defecation is highly disruptive and affects patients' recreation; stool urgency requires immediate access to bathrooms, which may result in pain and humiliating stool incontinence.) “Bowel Frequency,” “General Wellbeing,” and “Blood In Stool” show borderline significant P values that are not much higher compared with those of the total SCCAI.

also in 6,822 other papers

“Bowel Movements at Night” indicated a statistical trend with a two-sided P value of 0.127, whereas “Stool Urgency” resulted in a P value of 0.006.

also in 1,573 other papers